Amanta Healthcare appoints auditors for FY 2026-27

1 min read     Updated on 20 May 2026, 05:57 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Amanta Healthcare's Board has appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for a five-year term from FY 2026-27 to FY 2030-31, pending shareholder approval. Additionally, the firm re-appointed M/s. Parikh Shah & Associates as Internal Auditor and M/s Y S THAKAR & Co. as Cost Auditor for the financial year 2026-27.

powered bylight_fuzz_icon
40741436

*this image is generated using AI for illustrative purposes only.

The Board of Directors of amanta healthcare has approved the appointment and re-appointment of statutory auditors for the company. The decisions were taken during a meeting held on May 19, 2026, pursuant to the recommendations of the Audit Committee.

The Board appointed M/s. Kashyap R. Mehta & Partners, Practicing Company Secretaries, as the Secretarial Auditor for a term of five consecutive years. This term commences from the financial year 2026-27 and continues until the financial year 2030-31. However, this appointment is subject to the approval of shareholders at the ensuing Annual General Meeting.

In addition to the new appointment, the Board approved the re-appointment of M/s. Parikh Shah & Associates, Chartered Accountants, as the Internal Auditor of the company for the financial year 2026-27. The firm, incorporated on May 29, 2003, provides statutory and tax audits, internal audits, and management advisory services.

Furthermore, M/s Y S THAKAR & Co., Cost Accountants, were re-appointed as the Cost Auditor for the financial year 2026-27. Established in 2011, the firm is a leading partnership of Cost and Management Accountants in Gujarat with a client base exceeding 120 and a track record of filing over 2000 cost audit reports.

Auditor Appointments Summary

Auditor Firm Name Tenure / Period Purpose
Secretarial Auditor M/s. Kashyap R. Mehta & Partners FY 2026-27 to FY 2030-31 Appointment subject to shareholder approval
Internal Auditor M/s. Parikh Shah & Associates FY 2026-27 Re-appointment
Cost Auditor M/s Y S THAKAR & Co. FY 2026-27 Re-appointment

The company confirmed that there are no relationships to disclose between the Directors inter se, the Manager, and the Key Managerial Personnel (KMPs) regarding these appointments.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.74%+5.91%+0.92%+19.87%-6.00%-6.00%

How might the five-year tenure of M/s. Kashyap R. Mehta & Partners as Secretarial Auditor impact Amanta Healthcare's corporate governance transparency and compliance framework going forward?

What potential findings or recommendations from the newly appointed auditors could influence Amanta Healthcare's operational or financial strategy in FY 2026-27?

Will shareholders raise any concerns or opposition during the ensuing Annual General Meeting regarding the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditor?

Amanta Healthcare revises CMD remuneration to ₹13.29 lakh

1 min read     Updated on 20 May 2026, 05:56 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Amanta Healthcare's board approved revising the Chairman & Managing Director's remuneration to ₹13.29 lakh per month, up from ₹10 lakh, effective April 1, 2026. This change is subject to shareholder approval via a Special Resolution at the upcoming Annual General Meeting.

powered bylight_fuzz_icon
40741546

*this image is generated using AI for illustrative purposes only.

The Board of Directors of amanta healthcare has approved a revision in the remuneration of its Chairman & Managing Director, Shri Bhavesh Girishbhai Patel. The decision was taken during a board meeting held on May 19, 2026. The revised remuneration is set at 13,29,000 P.M., compared to the existing remuneration of 10,00,000 P.M.

Remuneration Details

The increase in remuneration is effective from April 1, 2026. The appointment period will extend from the date of the Board Meeting until further re-appointment. The revision requires the approval of shareholders by way of a Special Resolution at the ensuing Annual General Meeting.

Particulars Details
Name of Director Shri Bhavesh Girishbhai Patel
Designation Chairman & Managing Director
Existing Remuneration 10,00,000 P.M.
Revised Remuneration Proposed 13,29,000 P.M.
Effective Date April 1, 2026
Period From Board Meeting till further re-appointment
Nature of Change Revision in remuneration
Approval Required Shareholders’ approval by way of Special Resolution

Meeting Proceedings

The board meeting commenced at 12:15 PM and concluded at 03:10 PM on May 19, 2026. The company has submitted the disclosure to the stock exchanges under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.74%+5.91%+0.92%+19.87%-6.00%-6.00%

How might shareholders respond to the 32.9% remuneration hike at the upcoming AGM, and what is the likelihood of the Special Resolution being passed?

Does the revised remuneration of Shri Bhavesh Girishbhai Patel align with industry benchmarks for CMD compensation in comparable mid-cap healthcare companies?

Could this remuneration revision signal broader strategic changes or expansion plans at Amanta Healthcare that investors should watch for?

More News on Amanta Healthcare

1 Year Returns:-6.00%